Kite Pharma, Inc.: cashflow_investing

Value{"amount": -160139000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2014-01-01 – 2014-12-31
Statuscurrent
EntityKite Pharma, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001510580-17-000003 · Open the official SEC filing →
Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001510580/cashflow-investing/2014-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/2a73aee6-d0b6-4d32-82e6-535be91c20cc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies